AM

Adas3d Medical

www.adas3d.com link_icon

Company Research Report: ADAS3D Medical



Company Overview



Name


ADAS3D Medical S.L.

Mission of the Company


ADAS3D Medical's mission is to improve the prognosis of cardiovascular patients by expanding the accessibility and use of Cardiac Imaging (MRI and CT) to electrophysiology procedures.

Founding Information


ADAS3D Medical is a recent offspring of the electrophysiology business of Galgo Medical, founded in 2013, and emerged from Universitat Pompeu Fabra in Spain.

Key People


  • Antoni Riu - Managing Director

  • Luis Serra - President

  • Jacobo Gil de Biedma - Business Development Director

  • Xavi Planes - Chief Technology Officer

  • Francia Rojas - Quality and Regulatory Affairs Director


Headquarters


Rambla Catalunya, 53, 4º-H, 08007, Barcelona, Spain

Number of Employees


No information is available.

Revenue


No information is available.

Notable Aspects


ADAS3D Medical is known for its advanced cardiac imaging technologies aimed at extracting and understanding key information from cardiac MRI and CT images for electrophysiologists, enhancing decision-making before, during, and after EP interventions.

Products



ADAS 3D LV


  • Description: Utilizes MRI to analyze the fibrotic tissue of the left ventricle, visualizing it and calculating anatomical corridors.

  • Key Features: Combines MRI data with CT anatomy to provide comprehensive insights into left ventricle fibrosis.


ADAS 3D LA


  • Description: Designed to understand the fibrotic substrate of the left atrium, aiding in clinical decision-making for re-interventions.

  • Key Features: Important for both pre and peri-procedural planning.


Key Features Across Products


  • Insights and Decision Making: Information extracted helps in deciding treatment approaches.

  • Intervention Guidance: Models can be used as roadmaps during procedures.

  • Autonomous Segmentation: Users can analyze multiple patients independently.

  • Fibrosis Quantification: Quantifies and visualizes heart fibrosis via MRI.

  • Anatomy Visualization: Provides detailed 3D heart anatomy visualization through CT.

  • Artificial Intelligence: Automated segmentations for specific image sequences (feature coming soon).


Recent Developments



Recent Events and Participation


  • ADAS3D showcased its cardiac imaging solutions at the Heart Rhythm Society Congress in Boston (May 16-19, 2024).

  • Highlighted latest innovations at EHRA 2024 Congress in Berlin (April 7-9, 2024).


New Approvals


  • Secured Chinese NMPA approval for software distribution, facilitating expansion in the Chinese market.


Partnerships and Collaborations


No information is available.

New Product Launches


No information is available.

New Features


The company is preparing to launch a new feature involving automated segmentation powered by AI in the next software release.

This report encapsulates the current standing and progress of ADAS3D Medical based on the provided data. Further detailed insights could be developed with additional financial and market engagement data.